Biomaterial Database

Delayed primary wound closure in gangrenous and perforated appendicitis. 1981

R A Pettigrew

A prospective randomized trial was performed on 122 patients with perforated or gangrenous appendicitis to determine whether delayed primary wound closure lowered morbidity from wound infection. The 54 per cent wound infection rate with delayed primary closure was significantly inferior to the 18 per cent infection rate for primary closure with topical ampicillin powder (P = 0.0082), but not significantly different from the 37 per cent infection rate for primary closure alone. Furthermore, patients disliked delayed primary closure, their hospital stay was prolonged and 17 per cent of their wounds became contaminated with Staphylococci before being closed. Delayed primary wound closure should not be used in treating perforated and gangrenous appendicitis wounds.

UI	MeSH Term	Description	Entries
D007416	Intestinal Perforation	Opening or penetration through the wall of the INTESTINES.	Intestinal Perforations,Perforation, Intestinal,Perforations, Intestinal
D008297	Male		Males
D008722	Methods	A series of steps taken in order to conduct research.	Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D011446	Prospective Studies	Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.	Prospective Study,Studies, Prospective,Study, Prospective
D011897	Random Allocation	A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects.	Randomization,Allocation, Random
D002986	Clinical Trials as Topic	Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.	Clinical Trial as Topic
D005260	Female		Females
D005734	Gangrene	Death and putrefaction of tissue usually due to a loss of blood supply.	Gangrenes
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults